emoxypine succinate has been researched along with reamberin in 18 studies
| Studies (emoxypine succinate) | Trials (emoxypine succinate) | Recent Studies (post-2010) (emoxypine succinate) | Studies (reamberin) | Trials (reamberin) | Recent Studies (post-2010) (reamberin) |
|---|---|---|---|---|---|
| 310 | 60 | 130 | 148 | 46 | 117 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mester, KM; Volchegorskiĭ, IA | 1 |
| Astakhova, TV; Mester, KM; Miroshnichenko, IY; Novoselov, PN; Rassokhina, LM; Volchegorskii, IA | 1 |
| Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 2 |
| Berdnikova, EV; Dmitrienko, VN; Rykun, VS; Soliannikova, OV; Sumina, MS; Tur, EV; Volchegorskiĭ, IA | 1 |
| Pravdin, EV; Uzlova, TV; Volchegorskiĭ, IA | 3 |
| Abramov, OV; Butiugin, IA; Kornilova, NV | 1 |
| Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA | 1 |
| Iakubovskiĭ, SV; Kondratenko, GG; Leonovich, SI; Popova, II | 1 |
| Faĭzullin, RM; Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Faĭzullin, RM; Miroshnichenko, IIu; Priakhina, KE; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Faĭzullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, II; Priakhina, KE; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Faizullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, IA | 2 |
| Faizullin, RM; Kalugina, AV; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, LA | 1 |
| Pospelova, AV; Pravdin, EV; Uzlova, TV; Volchegorskii, IA | 1 |
5 trial(s) available for emoxypine succinate and reamberin
| Article | Year |
|---|---|
[Effectiveness of 3-hydroxypyridine and succinic acid derivatives in complex treatment of primary open-angle glaucoma].
Topics: Adult; Aged; Antioxidants; Blood Flow Velocity; Female; Glaucoma, Open-Angle; Humans; Lipids; Male; Meglumine; Middle Aged; Optic Disk; Optic Nerve; Picolines; Prospective Studies; Succinates; Time Factors | 2012 |
[Effect of 3-oxypyridine and succinic acid derivatives on affective status in recrudescence of inflammatory diseases of uterus and its appendages].
Topics: Adnexa Uteri; Adolescent; Adult; Antioxidants; Brain; Depressive Disorder; Female; Genital Diseases, Female; Humans; Inflammation; Interleukin-1beta; Meglumine; Middle Aged; Phagocytosis; Picolines; Prospective Studies; Pyridines; Recurrence; Succinates; Succinic Acid; Tumor Necrosis Factor-alpha; Uterus | 2012 |
[Comparative effectiveness study of local antioxidants in complex treatment of chronic periodontal disease].
Topics: Adult; Antioxidants; Chronic Periodontitis; Combined Modality Therapy; Female; Humans; Lipid Peroxidation; Male; Meglumine; Oral Hygiene Index; Picolines; Succinates; Tocopherols; Treatment Outcome | 2013 |
[Effect of 3-oxypyridine and succinic acid derivatives on endometrial leucocyte infiltration and lipid peroxidation in recrudescence of inflammatory diseases of the uterus and its appendages].
Topics: Adolescent; Adult; alpha-Tocopherol; Antioxidants; Ceruloplasmin; Endometrium; Female; Humans; Inflammation; Lipid Peroxidation; Meglumine; Middle Aged; Picolines; Prospective Studies; Pyridines; Single-Blind Method; Succinates; Ureteral Diseases | 2013 |
[Effect of 3-oxypyridine and succinic acid derivatives on clinical manifestations of inflammatory diseases of the uterus and its appendages].
Topics: Adult; Antioxidants; Female; Humans; Inflammation; Meglumine; Middle Aged; Pelvic Inflammatory Disease; Picolines; Prospective Studies; Succinates; Uterine Diseases | 2013 |
13 other study(ies) available for emoxypine succinate and reamberin
| Article | Year |
|---|---|
[Effects of 3-hydroxypyridine and succinic acid derivates on the dynamics of vertebral/neurologic symptoms after the surgical treatment of disk herniations].
Topics: Adult; Female; Humans; Intervertebral Disc Displacement; Male; Meglumine; Middle Aged; Neuralgia; Picolines; Postoperative Period; Pyridines; Spine; Succinates | 2010 |
Effect of pro- and antioxidants on insulin sensitivity and glucose tolerance.
Topics: Animals; Antioxidants; Blood Glucose; Brain; In Vitro Techniques; Insulin Resistance; Lipid Peroxidation; Meglumine; Picolines; Rats; Reactive Oxygen Species; Statistics, Nonparametric; Succinates; Thioctic Acid | 2011 |
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hippocampus; Learning; Lipid Metabolism; Lipid Peroxidation; Male; Meglumine; Motor Activity; Neurons; Neuroprotective Agents; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2011 |
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hyperlipidemias; Hypoxia; Male; Meglumine; Mice; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Thioctic Acid | 2011 |
Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.
Topics: Alloxan; Animals; Astrocytes; Cerebral Cortex; Diabetes Mellitus, Experimental; Diencephalon; Female; Hippocampus; Hyperglycemia; Male; Meglumine; Neurons; Neuroprotective Agents; Oligodendroglia; Paraventricular Hypothalamic Nucleus; Picolines; Rats; Succinates; Thioctic Acid | 2013 |
[Changes of oxidative homeostasis in acute experimental cholecystitis].
Topics: Animals; Antioxidants; Blood Proteins; Catalase; Cholecystitis, Acute; Disease Models, Animal; Female; Guinea Pigs; Injections, Intramuscular; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Meglumine; Oxidation-Reduction; Oxidative Stress; Picolines; Succinates; Superoxide Dismutase | 2012 |
[Experimental study of 3-oxypiridine and succinic acid derivates antidepressant activity in mice].
Topics: Amitriptyline; Animals; Animals, Outbred Strains; Antidepressive Agents; Behavior, Animal; Female; Immobilization; Male; Meglumine; Mice; Panic; Picolines; Succinates; Swimming; Thioctic Acid | 2013 |
[The effect of 3-oxypyridine and succinic acid derivatives on obsessive-compulsive activity of mice in marble-burying test].
Topics: Amitriptyline; Animals; Behavior, Animal; Disease Models, Animal; Female; Humans; Hypnotics and Sedatives; Male; Meglumine; Mice; Motor Activity; Obsessive-Compulsive Disorder; Picolines; Psychotropic Drugs; Succinates; Thioctic Acid | 2014 |
[The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].
Topics: Acute Disease; Animals; Brain Ischemia; Disease Models, Animal; Female; Male; Meglumine; Mice; Picolines; Pyridines; Succinates; Thioctic Acid | 2014 |
Comparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Female; Male; Meglumine; Picolines; Pyridines; Rats; Risk-Taking; Succinates; Succinic Acid | 2015 |
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Depression; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; Meglumine; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2015 |
[Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].
Topics: Animals; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Female; Male; Meglumine; Picolines; Psychotropic Drugs; Pyridines; Rats; Succinates; Succinic Acid | 2015 |
EFFECT OF 3-HYDROXYPYRIDINE AND SUCCINIC ACID DERIVATIVES ON BACTERIAL GROWTH IN DISCONTINUOUS CULTURES.
Topics: Antioxidants; Colony Count, Microbial; Enterococcus faecalis; Escherichia coli; Hormesis; Meglumine; Picolines; Staphylococcus aureus; Succinates | 2016 |